Projects per year
Organization Profile
Organisation profile
With thousands of years of history, the development of Chinese medicine has made a tremendous contribution to the proliferation and prosperity of the nations of China and neighboring countries. Owing to the great breadth and profundity of its theories and proven efficacy, Chinese medicine has become a new focus of attention for scientists all over the world. Committed to both inheritance and innovation in Chinese medicine, the School of Chinese Medicine (SCM) of Hong Kong Baptist University (HKBU) makes full use of modern technologies to conduct innovative research on standardisation of Chinese medicine and integration of Chinese medicine and western medicine, and contributes to the internationalisation of Chinese medicine.
The fundamental research strength of SCM lies in the academic and research experts who comprise the largest research team of Chinese medicine in Hong Kong. Riding on the University's strategy of fostering interdisciplinary research, the experts and researchers of SCM have been conducting innovative research on the traditional discipline of Chinese medicine which aims to discover new knowledge and create novel technologies for translation and application to benefit society, and they have produced very encouraging results on this front. The faculty members of SCM have produced substantial research outputs in international scientific journals and have been granted numerous patent rights from the US, European, the People's Republic of China and Hong Kong. In the results of the Research Assessment Exercise 2014 announced by the University Grants Committee, SCM outshone other institutions in the percentage of four-star rating (world leading) in the field of Chinese medicine. Looking ahead, SCM will continue to work hard and scale new heights in the research field of innovative drug discovery, precision medicine and phenome research based on Chinese medicine.
Fingerprint
Collaborations and top research areas from the last five years
Scholars
-
P. ASTHANA, Dr
- Chinese Medicine - Teaching and Research Division - Research Assistant Professor
Person
-
Kam Wa CHAN, Prof
- Chinese Medicine - Teaching and Research Division - Assistant Professor
- Vincent V.C. Woo Chinese Medicine Clinical Research Institute - Associate Director
Person
-
Studies on the Pharmacodynamics and Druggability of ANL2 as an Antiviral Drug Candidate against SARS-CoV-2
ZHANG, H. (PI) & YANG, Z. (CoI)
1/02/25 → 31/01/27
Project: Research project
-
Targeting osteoblastic 11β-HSD1 to combat high fat diet-induced bone loss, glucose handing impairment and obesity
LIU, J. (PI), WONG, H. L. X. (CoI), ZHANG, G. (CoI) & Wang, S. (CoI)
1/01/25 → 31/12/27
Project: Research project
-
Osteoblastic sclerostin loop3-LRP4 interaction could be required by sclerostin to inhibit bone formation
ZHANG, G. (PI) & WANG, L. (CoI)
1/01/25 → 31/12/27
Project: Research project
-
Adolescent exposure to micro/nanoplastics induces cognitive impairments in mice with neuronal morphological damage and multi-omic alterations
Wang, C., Lin, K., Zhang, Z., Pan, Y., Miao, Q., Han, X., Zhang, Z., Zhu, P., Yang, J., Peng, Y., Yung, K. K. L., Shi, L. & Zhang, S., Mar 2025, In: Environment International. 197, 13 p., 109323.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Alpha-1 Antitrypsin as a Regulatory Protease Inhibitor Modulating Inflammation and Shaping the Tumor Microenvironment in Cancer
Xiang, S., Yang, L., He, Y., Ding, F., Qiao, S., Su, Z., Chen, Z., Lu, A. & Li, F., 2 Jan 2025, In: Cells. 14, 2, 17 p., 88.Research output: Contribution to journal › Journal article › peer-review
Open Access -
An Integration of RNA Sequencing and Network Pharmacology Approaches Predicts the Molecular Mechanisms of the Huo-Xue-Shen Formula in the Treatment of Liver Fibrosis
Jiang, K., Bao, J., Lou, Z., Liu, F., Xu, K. & Kwan, H. Y., 7 Feb 2025, In: Pharmaceuticals. 18, 2, 24 p., 227.Research output: Contribution to journal › Journal article › peer-review
Open Access
Prizes
Activities
-
Pharmaceutics (Journal)
IYASWAMY, A. (Guest editor)
11 Jun 2025Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Hong Kong Society of Endocrinology, Metabolism and Reproduction (External organisation)
WONG, H. L. X. (Committee/panel/advisory board member)
2025 → 2027Activity: Membership › Membership of board/committee/council
-
International Journal of Molecular Sciences (Journal)
KWAN, H. Y. (Guest editor)
1 Jan 2025 → 31 Dec 2027Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
Press/Media
-
Press conference on potential of artemisinin derivative in treating human obesity
7/03/24
4 items of Media coverage, 2 Media contributions
Press/Media
-
-
HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment
6/12/23
1 item of Media coverage
Press/Media
Student theses
-
A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of MicroRans in osteoclasts
Dang, L. (Author), ZHANG, G. (Supervisor), 29 Apr 2016Student thesis: Master's Thesis
File -
A Material Evidence Base for Investigating the Evolution of Chinese Medicinal Varieties and Cross-cultural Exchange
Brand, E. J. (Author), ZHAO, Z. (Supervisor), 4 Sept 2017Student thesis: Doctoral Thesis
File -
A mechanistic study on the anti-melanoma action of quercetin
Cao, H. (Author), YU, Z. (Supervisor), 18 Feb 2015Student thesis: Doctoral Thesis
File